Bahrain vs Israel: The number of people with susceptibility test result for rifampicin
Bahrain
112
in 2021
Israel
103
in 2021
Bahrain rank
107th
Israel rank
108th
The number of people with susceptibility test result for rifampicin over time
- Bahrain
- Israel
How they compare
Bahrain currently reports 112 against 103 in Israel, a difference of 9.
That makes Bahrain's figure about 1.1 times Israel's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Israel ahead.
Bahrain ranks 107th and Israel ranks 108th of 155 countries.
Across the 2 decades both report, Bahrain averaged higher in 1 and Israel in 1.
Head to head by decade
| Decade | Bahrain | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84 | 129.33 | 45.33 | Israel |
| 2020s | 97 | 96 | 1 | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahrain or Israel?
- Bahrain, at 112 against 103 in Israel as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahrain and Israel?
- 9, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Israel?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahrain and Israel rank globally for the number of people with susceptibility test result for rifampicin?
- Bahrain ranks 107th and Israel ranks 108th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.